Researchers at the EADV Congress compared 575 users with 1,329 non-users and also found more hair shedding with scalp inflammation. Experts say not to stop treatment over it.
Recap by typeshit. Full story at Yahoo News New Zealand.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
In an eight-week monkey study, lean mass was 6% of weight lost with the antibody plus semaglutide versus 22% on semaglutide alone. iBio plans human trials in early 2027.
On the drug since November 2023, she says she still enjoys eating but food no longer takes over her life.
Loading…